
CAS 825600-90-6
:Lucinactant
Description:
Lucinactant is a synthetic surfactant primarily used in the medical field, particularly for the treatment of respiratory distress syndrome in premature infants. It is designed to mimic the natural surfactant found in the lungs, which plays a crucial role in reducing surface tension in the alveoli, thereby facilitating easier breathing. Lucinactant is characterized by its ability to improve lung function and oxygenation in patients with compromised respiratory systems. The substance is administered via intratracheal instillation and is formulated to enhance lung stability and reduce the risk of atelectasis. Its efficacy is attributed to its unique molecular structure, which allows it to spread evenly across the alveolar surface. Additionally, lucinactant is known for its safety profile, with a low incidence of adverse effects, making it a valuable therapeutic option in neonatal care. As a synthetic compound, it is produced under strict regulatory standards to ensure quality and consistency in its application.
Formula:Unspecified
Synonyms:- Surfaxin
- Lucinactant
- ATI 02
- KL4-surfactant
- KL-surfactant
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
Lucinactant
CAS:<p>Lucinactant is a peptide that belongs to the group of activators. It is a ligand for the receptor, which is classified as an ion channel and is activated by the binding of lucinactant. Lucinactant has been shown to be an inhibitor of life science research tools, such as antibodies and cells, by blocking their function.</p>Formula:C128H242N26O24Purity:Min. 95%Molecular weight:2,529.5 g/mol
